Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1992
11/02/1992CA2067663A1 Pyrazine derivatives
10/1992
10/31/1992WO1992019632A1 Trifluoromethyl analogs of fucose and uses thereof
10/31/1992CA2106785A1 Trifluoromethyl analogs of fucose and uses thereof
10/29/1992WO1992018496A1 New thalidomide derivatives, method of manufacture and use thereof in medicaments
10/29/1992WO1992018493A1 Benzopyranones, methods of manufacture and use thereof
10/29/1992WO1992018482A1 Novel cyclic aminophenylacetic acid derivative, production thereof, and immune response modulator containing the same as active ingredient
10/29/1992WO1992018150A1 Mhc conjugates useful in ameliorating autoimmunity
10/29/1992WO1992018112A1 Method of preventing nmda receptor complex-mediated neuronal damage
10/29/1992WO1992014743A3 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/29/1992CA2108174A1 Benzopyranones, methods of manufacture and use thereof
10/28/1992EP0511073A1 Antiserotonines, their preparation and medicaments containing them
10/28/1992EP0510949A2 Cytomodulating conjugates of members of specific binding pairs
10/28/1992EP0510948A1 N-Hydroxy ureae as 5-lipoxygenase inhibitors
10/28/1992EP0510947A1 N-Hydroxy (thio)ureas as 5-lipoxygenase inhibitors
10/28/1992EP0510904A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510903A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510748A1 Use of a methoxy alkanoic acid of indazole for the manufacture of a medicament for the treatment of autoimmune diseases
10/28/1992EP0510473A1 Thienyl-nonatetraenoic acid derivatives with anti-rheumatic activity
10/28/1992EP0510356A1 Polyethylene glycol protein conjugates
10/28/1992EP0510075A1 Human receptor of tsh. sequence coding for such receptor
10/27/1992WO1992019970A1 Methods to detect and treat diseases caused by bacterial allergens
10/27/1992WO1992019624A1 Antiserotonines, prepartion thereof and medicaments containing them
10/27/1992US5158977 Antioxidant; preventive treatment of cutaneous inflammations and allergies
10/27/1992US5158975 Use of stearidonic acid
10/27/1992US5158971 Pharmaceutical compounds
10/27/1992US5158940 Use of suramin to treat rheumatologic diseases
10/27/1992US5158939 Administering a nontoxic lipopolysaccharide from rhodopseudomonas which negate the inhibitory effects of thymus derived T suppressor cells
10/27/1992US5157894 Orientation and loading device for vials in general and syringe vials in particular
10/27/1992CA2109088A1 Methods to detect and treat diseases caused by bacterial allergens
10/27/1992CA2103562A1 Antiserotonins, preparation thereof and medicaments containing them
10/27/1992CA1309557C Leukotriene antagonists
10/27/1992CA1309414C Cycloalkano[1,2-b]indole-sulphonamides
10/27/1992CA1309407C Cinnoline-carboxamides and process for their preparation
10/27/1992CA1309346C Pharmaceutical administration systems containing chemotactic peptides
10/26/1992WO1992019732A1 Closed sense and antisense oligonucleotides and uses thereof
10/26/1992CA2102229A1 Closed sense and antisense oligonucleotides and uses thereof
10/25/1992CA2066826A1 Thienyl-nonatetraenoic acid derivatives
10/24/1992CA2066810A1 Cytomodulating conjugates of members of specific binding pairs
10/24/1992CA2066509A1 N-hydroxy-n-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas
10/24/1992CA2066508A1 N-hydroxy-n-(3-(2-(halophenylthio)phenyl) prop-2-enyl)-ureas as lipoxygenase inhibitors
10/24/1992CA2066499A1 Lipophilic macrolide useful as an immunosuppressant
10/24/1992CA2066494A1 Lipophilic macrolide useful as an immunosuppressant
10/23/1992WO1992018483A1 Quinoline derivatives
10/23/1992CA2108971A1 Quinoline derivatives
10/22/1992DE4211812A1 New water-soluble 2-(2,6-di:oxo-3-piperidinyl)-1H-iso-indole-1-di:one deriv. - may be administered parenterally and have comparable activity to thalidomide itself
10/21/1992EP0509795A2 Carbamates of rapamycin
10/21/1992EP0509753A1 Semi-synthetic immunosuppressive macrolides
10/21/1992EP0509656A1 Compositions of phytosterols and phytosterolins as immunmodulators
10/21/1992CN1065465A Polyethylene protein conjugates
10/21/1992CN1065460A Nonsaditive antihistaminics derived from benzimidazoles
10/20/1992WO1992018618A1 Modified plant viruses as vectors
10/20/1992US5157140 Esters of myo-inositol phosphate
10/20/1992US5157112 Antibodies immunoreactive with the T-cell growth factor, P40
10/20/1992US5157110 Synthetic, anti-complement protein
10/20/1992US5157052 Method for inhibiting ige production
10/20/1992US5156960 Microbial process for the production of immunosuppressive antibiotics
10/20/1992US5156949 Immunoassays for antibody to human immunodeficiency virus using recombinant antigens
10/20/1992CA2065658A1 Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
10/19/1992CA2066138A1 Semi-synthetic immunosuppressive macrolides
10/15/1992WO1992017198A1 Dna and amino acid sequence specific for natural killer cells
10/15/1992WO1992017172A1 Disubstituted naphthalenes
10/15/1992WO1992007939A3 Polypeptide with 46kd hmfg differentiation antigen binding specificity
10/15/1992DE4111861A1 Benzopyranone, verfahren zu ihrer herstellung und verwendung Benzopyranones, processes for their preparation and use
10/14/1992EP0508690A1 Tetronic and thiotetronic acid derivatives
10/14/1992EP0508334A2 Novel aminophenol derivatives and pharmaceutical compositions thereof
10/14/1992EP0507872A1 The use of arginine as an immunostimulator
10/14/1992CN1065264A Stereoselective preparation of substituted piperidines
10/14/1992CN1018646B Process for preparing glycoside
10/14/1992CN1018640B Process for the preparation of compounds for the induction of in vivo and in vitro production of cytokines
10/14/1992CN1018614B Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines
10/13/1992US5155106 Reduced side effects
10/13/1992US5155104 Phenylalkan(en)oic acid
10/13/1992US5155103 Methods of using new thieno-triazole-1,4-diazepino-2-carboxylic acid amides
10/13/1992CA2065228A1 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors
10/13/1992CA1308713C Pyrazolo[3,4-d]-pyrimidines, processes for the preparation thereof and pharmaceutical compositions containing them
10/13/1992CA1308681C Polyether ionophore, process of preparation and use
10/12/1992WO1992018506A1 Novel immunosuppressant agent from streptomyces braegensis
10/11/1992WO1992018463A1 Novel compounds and use thereof as medicine
10/11/1992CA2084779A1 Compound, and use of the same as medicine
10/09/1992CA2065526A1 Aminophenol derivatives and pharmaceutical compositions thereof
10/07/1992EP0507696A1 Antihistaminic and non-sedative derivatives of benzimidazol, process for their preparation and their medicinal use
10/07/1992EP0507556A1 Silyl ethers of rapamycin
10/07/1992EP0507337A2 Novel erucyl, brassidyl and nervonyl derivatives
10/07/1992EP0506890A1 Recombinant thyrotropin receptor
10/07/1992EP0506785A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
10/07/1992CN1065065A Process for preparing 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/07/1992CN1065062A Quinoline-containing ketoacids as leukotriene antagonists
10/07/1992CN1065009A Process for preparing composition for beauty or pharmaceutical, especially dermtoses and anti-allergy and use
10/06/1992WO1992017440A1 Tricyclic compound
10/06/1992US5153176 Substituted lysine-proline-arginine peptide
10/06/1992US5153173 N-acyl derivatives of the peptidoglycan monomer, pharmaceutically acceptable salts thereof, their preparation and use as immunomodulators and immunoadjuvants
10/06/1992CA2106979A1 Tricyclic compound
10/06/1992CA2065061A1 Benzimidazole-derived non sedative antihistamines
10/03/1992WO1992017173A2 Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria
10/03/1992CA2107078A1 Use of riboflavin in the treatment of hiv-linked diseases, herpes, retinitis pigmentosa and malaria
10/02/1992CA2063962A1 Silyl ethers of rapamycin
10/01/1992WO1992016666A1 N6-(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body
10/01/1992WO1992016600A1 Process for the extraction of peat and apparatus for carrying out the process
10/01/1992WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
10/01/1992WO1992016517A1 Pharmaceutical xanthone derivatives
1 ... 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 ... 1172